Invacare Corp (IVC) 17.13 $IVC
Invacare declares $0.0125 dividend
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 12:43PM CST
IVC: 17.13 (+0.15)
CORRECTING and REPLACING Invacare Declares Quarterly Dividend
Business Wire - Fri Feb 13, 12:14PM CST
Record date at the end of the first paragraph of release should read: April 2, 2015 (instead of April 3, 2015).
IVC: 17.13 (+0.15)
Invacare Declares Quarterly Dividend
Business Wire - Fri Feb 13, 10:48AM CST
The Board of Directors of Invacare Corporation (NYSE:IVC) announced that it declared a cash dividend of $.0125 per share on its common shares and $.011364 per share on its Class B common shares payable April 13, 2015 to shareholders of record on April 3, 2015.
IVC: 17.13 (+0.15)
China Oxygen Concentrator Industry Report 2015
M2 - Fri Feb 13, 6:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/4pd76c/china_oxygen) has announced the addition of the "China Oxygen Concentrator Industry Report 2015" report to their offering. Oxygen concentrator is a small medical oxygen-making device that can constantly provide concentrated oxygen. The oxygen concentrator can make the oxygen that accounts for 21% of the air into oxygen with the concentration of 90% or more through the machine for the patients whose oxygen concentration in blood is insufficient or hypoxia people. It is applied in medical institutions and homes to provide oxygen therapy and oxygen care. In recent years, as people's living standard improves, people pay more attention to their health. As a new physical enhancement and disease prevention technology, oxygen therapy and oxygen care is being gradually accepted and popularized. The new industry, as a result, is rising and picking up momentum. Especially in recent years, as the promotion in the domestic market advances, the oxygen concentrator has gradually reached a boarder home market from the medical sector like hospitals, sanatoriums, etc. According to the statics, there are more than 1 million home users in the country. Yuwell, Xinsong, Turtles, Longfei, Air, Aoji, Youngleda, Gaoxin Huakuang, Haiyang Zhijia and other well-known brands in the market. Key Topics Covered: - Overview On Development Of Oxygen Concentrator - Analysis Of Development Environment Of Oxygen Concentrator Industry In China - Analysis Of Supply And Demand Of China's Oxygen Concentrator Market In 2013 - Analysis Of Regional Market Demand Of Oxygen Concentrator 2013 - Related Industry Analysis Of Oxygen Concentrator Industry - The Analysis Of Import And Export Data Of Oxygen Concentrator 2009-2014 - The Analysis Of The Main Oxygen Concentrator Manufactures - Development Trend And Prospect Analysis Of Oxygen Concentrator Industry In China From 2015 To 2020 - Analysis Of Investment And Financing Strategy Plan Of Oxygen Concentrator Enterprises Companies Mentioned - Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. - Beijing North Star Yaao Scitech Co., Ltd. - Zhejiang Longfei Industrial Co., Ltd. - Shenyang Changtai Medical Technology Limited Company - Shenyang Xinsong Medical Technology Co., Ltd. - Beijing Aoji Technology Development Co., Ltd. - Invacare Medical Equipment Co., Ltd - Qingdao Haiyang Yibai Industrial Limited Company - Basic Information About Foshan Shunde Bond Electric Co., Ltd. - Shandong Kehua Health Technology Limited Company For more information visit http://www.researchandmarkets.com/research/4p...ina_oxygen
IVC: 17.13 (+0.15)
Strategy To YieldBoost Invacare Corp To 25.6% Using Options
at The Street - Thu Feb 12, 10:37AM CST
Shareholders of Invacare Corp looking to boost their income beyond the stock's 0.3% annualized dividend yield can sell the May covered call at the $17.50 strike and collect the premium based on the $1.10 bid, which annualizes to an additional 25.3%...
IVC: 17.13 (+0.15)
Invacare (IVC) Upgraded From Sell to Hold
at The Street - Mon Feb 09, 12:20PM CST
Invacare (IVC) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C-.
IVC: 17.13 (+0.15)
Invacare (IVC) Crumbles: Stock Falls by 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 7:50AM CST
Invacare's shares fell 6% on the day trading at a volatile range in the past one-month time frame, showed a sharp decline Friday at $16.82.
BRLI: 34.63 (+0.06), IVC: 17.13 (+0.15)
Invacare (IVC) Reports Narrower Q4 Loss, Beats on Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:29AM CST
Invacare Corp. (IVC) reported adjusted loss of 12 cents per share in the fourth quarter of 2014, which was narrower than the Zacks Consensus Estimate of a loss of 23 cents
ABMD: 60.39 (+0.46), IVC: 17.13 (+0.15), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Why Invacare Corporation's Shares Skyrocketed Higher
Todd Campbell, The Motley Fool - Motley Fool - Thu Feb 05, 1:25PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Invacare Corporation 's shares surged by nearly 20%...
IVC: 17.13 (+0.15)
Invacare Q4 and FY14 results
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 12:02PM CST
IVC: 17.13 (+0.15)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 11:45AM CST
IMMU: 3.84 (unch), AXGN: 3.45 (+0.02), CLW: 63.20 (-0.74), QKLS: 2.10 (-0.24), EOPN: 8.55 (-0.01), HSNI: 67.32 (+1.52), LQDT: 9.52 (+0.09), EOX: 1.15 (unch), GLUU: 5.12 (+0.14), WSTL: 1.45 (+0.10), LFVN: 1.11 (-0.02), HSP: 87.35 (unch), GENE: 8.04 (+1.90), ADEP: 6.93 (-0.30), EARS: 5.88 (-0.01), IVC: 17.13 (+0.15), QUIK: 2.17 (+0.01), ENRJ: 2.81 (+0.06), FARM: 24.00 (-0.19), OSUR: 8.13 (+0.06)
Invacare Corporation's (IVC) CEO Robert Gudbranson on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 05, 10:56AM CST
IVC: 17.13 (+0.15)
Money flow surges into Invacare
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 9:43AM CST
IVC: 17.13 (+0.15)
Invacare beats by $0.15, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 5:41AM CST
IVC: 17.13 (+0.15)
Invacare Corporation Announces Financial Results for the Quarter and Year Ended December 31, 2014
Business Wire - Thu Feb 05, 5:30AM CST
Invacare Corporation (NYSE: IVC) today announced its financial results for the quarter and year ended December 31, 2014.
IVC: 17.13 (+0.15)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 4:30PM CST
FIS: 66.52 (+0.33), PRGO: 150.90 (+0.22), LAZ: 50.90 (+0.18), CHTR: 177.88 (+0.85), LQDT: 9.52 (+0.09), CFX: 52.02 (+3.84), KORS: 73.27 (+1.72), OZM: 11.93 (-0.14), PTEN: 18.14 (+1.13), DLPH: 78.70 (+0.64), DNKN: 46.70 (-0.69), DFT: 31.83 (-0.17), AMSC: 0.80 (+0.02), APO: 23.70 (+0.36), SNCR: 43.89 (+1.06), PRLB: 74.00 (+2.60), CSL: 94.14 (-0.09), SIRI: 3.83 (-0.07), PBH: 39.07 (+0.27), COTY: 22.03 (unch), RSTI: 24.12 (+0.20), IT: 81.53 (+1.64), ADS: 286.61 (+1.70), AINV: 7.71 (+0.15), AZN: 69.96 (+0.20), BCE: 44.74 (+0.14), NGD: 3.73 (-0.04), EL: 82.49 (+1.58), BCO: 25.73 (+0.18), RFP: 19.03 (+0.40), ODFL: 76.25 (+0.96), BDX: 143.71 (+0.72), GRA: 101.61 (+1.69), SNA: 145.40 (+0.71), BR: 52.59 (-0.29), BLL: 74.93 (+0.89), GRUB: 39.93 (+1.71), SBH: 33.10 (+0.28), ARW: 61.98 (+0.78), ETR: 79.12 (-1.53), BDC: 87.78 (+0.61), IVC: 17.13 (+0.15), CMI: 139.04 (+2.41), S: 5.23 (+0.08), PPL: 34.69 (-0.16), NUS: 56.92 (-1.30), MMP: 80.41 (-0.86), MMS: 59.14 (+0.12), MSCI: 57.20 (unch), MDSO: 46.58 (+1.48), ICE: 233.22 (-1.21), FBP: 6.35 (-0.02), LIOX: 5.57 (+0.10), CI: 114.47 (-0.51), PM: 82.87 (-0.82), EQT: 81.18 (+0.43), GPI: 84.34 (-0.74), ABB: 21.34 (+0.27), GPK: 15.41 (+0.29), GLT: 24.89 (+0.04), EQM: 88.04 (+0.96)
New chief at Invacare
Seeking Alpha - at Seeking Alpha - Thu Jan 22, 7:38AM CST
IVC: 17.13 (+0.15)
Invacare Corporation Names Matthew E. Monaghan President and Chief Executive Officer
Business Wire - Thu Jan 22, 7:01AM CST
Invacare Corporation (NYSE: IVC) announced today that it has appointed Matthew E. Monaghan as President and Chief Executive Officer, effective April 1, 2015. Mr. Monaghan's appointment follows an extensive global search conducted by an executive search firm under the direction of the Invacare Board of Directors. Mr. Monaghan, 47, will join Invacare with a breadth of general management, medical device and turnaround experience within global companies. Robert K. Gudbranson will continue to serve as Interim President and Chief Executive Officer until Mr. Monaghan joins the Company, after which time Mr. Gudbranson will continue as Senior Vice President and Chief Financial Officer.
IVC: 17.13 (+0.15)
Invacare reports February 5
Seeking Alpha - at Seeking Alpha - Tue Jan 20, 8:08AM CST
IVC: 17.13 (+0.15)
Invacare Corporation to Announce Financial Results for Fourth Quarter and Year Ended December 31, 2014
Business Wire - Tue Jan 20, 7:02AM CST
Invacare Corporation (NYSE: IVC) announces that it will release its financial results for the quarter and year ended December 31, 2014, before the market opens on Thursday, February 5, 2015. The Company will sponsor a conference call for investors and other interested parties on Thursday, February 5, at 8:30 AM EST to discuss the Company's performance.
IVC: 17.13 (+0.15)
Invacare declares $0.0125 dividend
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 12:43PM CST
IVC: 17.13 (+0.15)
CORRECTING and REPLACING Invacare Declares Quarterly Dividend
Business Wire - Fri Feb 13, 12:14PM CST
Record date at the end of the first paragraph of release should read: April 2, 2015 (instead of April 3, 2015).
IVC: 17.13 (+0.15)
Invacare Declares Quarterly Dividend
Business Wire - Fri Feb 13, 10:48AM CST
The Board of Directors of Invacare Corporation (NYSE:IVC) announced that it declared a cash dividend of $.0125 per share on its common shares and $.011364 per share on its Class B common shares payable April 13, 2015 to shareholders of record on April 3, 2015.
IVC: 17.13 (+0.15)
China Oxygen Concentrator Industry Report 2015
M2 - Fri Feb 13, 6:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/4pd76c/china_oxygen) has announced the addition of the "China Oxygen Concentrator Industry Report 2015" report to their offering. Oxygen concentrator is a small medical oxygen-making device that can constantly provide concentrated oxygen. The oxygen concentrator can make the oxygen that accounts for 21% of the air into oxygen with the concentration of 90% or more through the machine for the patients whose oxygen concentration in blood is insufficient or hypoxia people. It is applied in medical institutions and homes to provide oxygen therapy and oxygen care. In recent years, as people's living standard improves, people pay more attention to their health. As a new physical enhancement and disease prevention technology, oxygen therapy and oxygen care is being gradually accepted and popularized. The new industry, as a result, is rising and picking up momentum. Especially in recent years, as the promotion in the domestic market advances, the oxygen concentrator has gradually reached a boarder home market from the medical sector like hospitals, sanatoriums, etc. According to the statics, there are more than 1 million home users in the country. Yuwell, Xinsong, Turtles, Longfei, Air, Aoji, Youngleda, Gaoxin Huakuang, Haiyang Zhijia and other well-known brands in the market. Key Topics Covered: - Overview On Development Of Oxygen Concentrator - Analysis Of Development Environment Of Oxygen Concentrator Industry In China - Analysis Of Supply And Demand Of China's Oxygen Concentrator Market In 2013 - Analysis Of Regional Market Demand Of Oxygen Concentrator 2013 - Related Industry Analysis Of Oxygen Concentrator Industry - The Analysis Of Import And Export Data Of Oxygen Concentrator 2009-2014 - The Analysis Of The Main Oxygen Concentrator Manufactures - Development Trend And Prospect Analysis Of Oxygen Concentrator Industry In China From 2015 To 2020 - Analysis Of Investment And Financing Strategy Plan Of Oxygen Concentrator Enterprises Companies Mentioned - Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. - Beijing North Star Yaao Scitech Co., Ltd. - Zhejiang Longfei Industrial Co., Ltd. - Shenyang Changtai Medical Technology Limited Company - Shenyang Xinsong Medical Technology Co., Ltd. - Beijing Aoji Technology Development Co., Ltd. - Invacare Medical Equipment Co., Ltd - Qingdao Haiyang Yibai Industrial Limited Company - Basic Information About Foshan Shunde Bond Electric Co., Ltd. - Shandong Kehua Health Technology Limited Company For more information visit http://www.researchandmarkets.com/research/4p...ina_oxygen
IVC: 17.13 (+0.15)
Strategy To YieldBoost Invacare Corp To 25.6% Using Options
at The Street - Thu Feb 12, 10:37AM CST
Shareholders of Invacare Corp looking to boost their income beyond the stock's 0.3% annualized dividend yield can sell the May covered call at the $17.50 strike and collect the premium based on the $1.10 bid, which annualizes to an additional 25.3%...
IVC: 17.13 (+0.15)
Invacare (IVC) Upgraded From Sell to Hold
at The Street - Mon Feb 09, 12:20PM CST
Invacare (IVC) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C-.
IVC: 17.13 (+0.15)
Invacare (IVC) Crumbles: Stock Falls by 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 7:50AM CST
Invacare's shares fell 6% on the day trading at a volatile range in the past one-month time frame, showed a sharp decline Friday at $16.82.
BRLI: 34.63 (+0.06), IVC: 17.13 (+0.15)
Invacare (IVC) Reports Narrower Q4 Loss, Beats on Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:29AM CST
Invacare Corp. (IVC) reported adjusted loss of 12 cents per share in the fourth quarter of 2014, which was narrower than the Zacks Consensus Estimate of a loss of 23 cents
ABMD: 60.39 (+0.46), IVC: 17.13 (+0.15), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Why Invacare Corporation's Shares Skyrocketed Higher
Todd Campbell, The Motley Fool - Motley Fool - Thu Feb 05, 1:25PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Invacare Corporation 's shares surged by nearly 20%...
IVC: 17.13 (+0.15)
Invacare Q4 and FY14 results
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 12:02PM CST
IVC: 17.13 (+0.15)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 11:45AM CST
IMMU: 3.84 (unch), AXGN: 3.45 (+0.02), CLW: 63.20 (-0.74), QKLS: 2.10 (-0.24), EOPN: 8.55 (-0.01), HSNI: 67.32 (+1.52), LQDT: 9.52 (+0.09), EOX: 1.15 (unch), GLUU: 5.12 (+0.14), WSTL: 1.45 (+0.10), LFVN: 1.11 (-0.02), HSP: 87.35 (unch), GENE: 8.04 (+1.90), ADEP: 6.93 (-0.30), EARS: 5.88 (-0.01), IVC: 17.13 (+0.15), QUIK: 2.17 (+0.01), ENRJ: 2.81 (+0.06), FARM: 24.00 (-0.19), OSUR: 8.13 (+0.06)
Invacare Corporation's (IVC) CEO Robert Gudbranson on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 05, 10:56AM CST
IVC: 17.13 (+0.15)
Money flow surges into Invacare
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 9:43AM CST
IVC: 17.13 (+0.15)
Invacare beats by $0.15, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 5:41AM CST
IVC: 17.13 (+0.15)
Invacare Corporation Announces Financial Results for the Quarter and Year Ended December 31, 2014
Business Wire - Thu Feb 05, 5:30AM CST
Invacare Corporation (NYSE: IVC) today announced its financial results for the quarter and year ended December 31, 2014.
IVC: 17.13 (+0.15)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 4:30PM CST
FIS: 66.52 (+0.33), PRGO: 150.90 (+0.22), LAZ: 50.90 (+0.18), CHTR: 177.88 (+0.85), LQDT: 9.52 (+0.09), CFX: 52.02 (+3.84), KORS: 73.27 (+1.72), OZM: 11.93 (-0.14), PTEN: 18.14 (+1.13), DLPH: 78.70 (+0.64), DNKN: 46.70 (-0.69), DFT: 31.83 (-0.17), AMSC: 0.80 (+0.02), APO: 23.70 (+0.36), SNCR: 43.89 (+1.06), PRLB: 74.00 (+2.60), CSL: 94.14 (-0.09), SIRI: 3.83 (-0.07), PBH: 39.07 (+0.27), COTY: 22.03 (unch), RSTI: 24.12 (+0.20), IT: 81.53 (+1.64), ADS: 286.61 (+1.70), AINV: 7.71 (+0.15), AZN: 69.96 (+0.20), BCE: 44.74 (+0.14), NGD: 3.73 (-0.04), EL: 82.49 (+1.58), BCO: 25.73 (+0.18), RFP: 19.03 (+0.40), ODFL: 76.25 (+0.96), BDX: 143.71 (+0.72), GRA: 101.61 (+1.69), SNA: 145.40 (+0.71), BR: 52.59 (-0.29), BLL: 74.93 (+0.89), GRUB: 39.93 (+1.71), SBH: 33.10 (+0.28), ARW: 61.98 (+0.78), ETR: 79.12 (-1.53), BDC: 87.78 (+0.61), IVC: 17.13 (+0.15), CMI: 139.04 (+2.41), S: 5.23 (+0.08), PPL: 34.69 (-0.16), NUS: 56.92 (-1.30), MMP: 80.41 (-0.86), MMS: 59.14 (+0.12), MSCI: 57.20 (unch), MDSO: 46.58 (+1.48), ICE: 233.22 (-1.21), FBP: 6.35 (-0.02), LIOX: 5.57 (+0.10), CI: 114.47 (-0.51), PM: 82.87 (-0.82), EQT: 81.18 (+0.43), GPI: 84.34 (-0.74), ABB: 21.34 (+0.27), GPK: 15.41 (+0.29), GLT: 24.89 (+0.04), EQM: 88.04 (+0.96)
New chief at Invacare
Seeking Alpha - at Seeking Alpha - Thu Jan 22, 7:38AM CST
IVC: 17.13 (+0.15)
Invacare Corporation Names Matthew E. Monaghan President and Chief Executive Officer
Business Wire - Thu Jan 22, 7:01AM CST
Invacare Corporation (NYSE: IVC) announced today that it has appointed Matthew E. Monaghan as President and Chief Executive Officer, effective April 1, 2015. Mr. Monaghan's appointment follows an extensive global search conducted by an executive search firm under the direction of the Invacare Board of Directors. Mr. Monaghan, 47, will join Invacare with a breadth of general management, medical device and turnaround experience within global companies. Robert K. Gudbranson will continue to serve as Interim President and Chief Executive Officer until Mr. Monaghan joins the Company, after which time Mr. Gudbranson will continue as Senior Vice President and Chief Financial Officer.
IVC: 17.13 (+0.15)
Invacare reports February 5
Seeking Alpha - at Seeking Alpha - Tue Jan 20, 8:08AM CST
IVC: 17.13 (+0.15)
Invacare Corporation to Announce Financial Results for Fourth Quarter and Year Ended December 31, 2014
Business Wire - Tue Jan 20, 7:02AM CST
Invacare Corporation (NYSE: IVC) announces that it will release its financial results for the quarter and year ended December 31, 2014, before the market opens on Thursday, February 5, 2015. The Company will sponsor a conference call for investors and other interested parties on Thursday, February 5, at 8:30 AM EST to discuss the Company's performance.
IVC: 17.13 (+0.15)
